Frontlight ResearchEarly access
Spinal muscular atrophy trials in France
11 of 13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Not yet taking people in FranceAAV9-ASAH1 intracisterna magna Gene Therapy (GNT0009) in Patients with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA - PME)
- Where
- Le Kremlin Bicetre Cedex, Paris
- Age
- Up to 17 years
- People
- 3
- Run by
- Genethon
See details and how to join2026-527323-10-00 - No phaseTaking peopleAssessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
- Where
- Paris
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Institut de Myologie, France
See details and how to joinNCT07321977 - Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Lille Cedex, Paris
- Age
- Up to 17 years
- People
- 30 worldwide
- Run by
- Scholar Rock Inc.
See details and how to join2024-520130-29-00 - Phase 3Not yet taking people in FranceA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Where
- Garches, Marseille, Toulouse
- Age
- 0 days to 42 days
- People
- 30 worldwide
- Run by
- Biogen
See details and how to joinNCT07221669 · EU 2025-524054-34-00 - Phase 3Not yet taking people in FranceA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Where
- Bordeaux, Brest, Montpellier Cedex 5, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
- Age
- 0 days to 7 months
- People
- 42 worldwide
- Run by
- Biogen
See details and how to joinNCT07444450 · EU 2025-523857-32-00 - Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Paris
- Age
- Up to 2 years
- People
- 52 worldwide
- Run by
- Scholar Rock, Inc.
See details and how to joinNCT07047144 - Phase 1Not yet taking people in FranceA Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Where
- Garches
- Age
- 3 years and over
- People
- 78 worldwide
- Run by
- Biogen
See details and how to joinNCT06555419 · EU 2024-514239-21-00 - No phaseTaking peopleEvaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
- Where
- Lyon, Paris, Saint-Etienne
- Age
- 6 years and over
- People
- 80
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT06562283 - No phaseTaking peopleCharacterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
- Where
- Brest, Bron, Garche, Lille, Marseille, Paris, Strasbourg, Toulouse
- Age
- 0 years to 16 years
- People
- 60
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT06321965 - No phaseTaking peopleLong Read Analysis in Spinal Muscular Atrophy - LOREASI
- Where
- Rouen
- Age
- 18 years and over
- People
- 27
- Run by
- University Hospital, Rouen
See details and how to joinNCT07332702 - No phaseTaking peopleTest of Aquatic Mobility of SMA Infants
- Where
- Garches
- Age
- Up to 12 months
- People
- 15
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06152302